Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.
العنوان: | Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus. |
---|---|
المؤلفون: | Kasela S; New York Genome Center, New York, NY, USA.; Department of Systems Biology, Columbia University, New York, NY, USA., Daniloski Z; New York Genome Center, New York, NY, USA.; Department of Biology, New York University, New York, NY, USA., Jordan TX; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., tenOever BR; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sanjana NE; New York Genome Center, New York, NY, USA.; Department of Biology, New York University, New York, NY, USA., Lappalainen T; New York Genome Center, New York, NY, USA.; Department of Biology, New York University, New York, NY, USA. |
المصدر: | MedRxiv : the preprint server for health sciences [medRxiv] 2021 Apr 13. Date of Electronic Publication: 2021 Apr 13. |
نوع المنشور: | Preprint |
اللغة: | English |
بيانات الدورية: | Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE |
مستخلص: | To date the locus with the most robust human genetic association to COVID-19 susceptibility is 3p21.31. Here, we integrate genome-scale CRISPR loss-of-function screens and eQTLs in diverse cell types and tissues to pinpoint genes underlying COVID-19 risk. Our findings identify SLC6A20 and CXCR6 as putative causal genes that mediate COVID-19 risk and highlight the usefulness of this integrative approach to bridge the divide between correlational and causal studies of human biology. Competing Interests: Competing interests N.E.S. is an advisor to Vertex. T.L. advises and has equity in Variant Bio, and is a member of the scientific advisory board of Goldfinch Bio. The remaining authors declare that they have no competing interests. |
التعليقات: | Update in: Genome Biol. 2021 Aug 23;22(1):242. (PMID: 34425859) |
References: | Cell. 2018 Nov 29;175(6):1701-1715.e16. (PMID: 30449622) N Engl J Med. 2020 Oct 15;383(16):1522-1534. (PMID: 32558485) J Exp Med. 1997 Jun 2;185(11):2015-23. (PMID: 9166430) Science. 2014 Jan 3;343(6166):84-87. (PMID: 24336571) N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013) PLoS Genet. 2020 Apr 20;16(4):e1008720. (PMID: 32310995) Nat Genet. 2021 Sep;53(9):1290-1299. (PMID: 34493866) J Virol. 2005 Feb;79(3):1686-700. (PMID: 15650194) Cell. 2021 Jan 7;184(1):92-105.e16. (PMID: 33147445) Nat Genet. 2018 Jul;50(7):956-967. (PMID: 29955180) Nat Methods. 2014 Aug;11(8):783-784. (PMID: 25075903) Eur J Hum Genet. 2020 Jun;28(6):715-718. (PMID: 32404885) Nature. 2015 Oct 1;526(7571):68-74. (PMID: 26432245) Amino Acids. 2015 Apr;47(4):693-705. (PMID: 25534429) Nat Med. 2020 Jul;26(7):1017-1032. (PMID: 32651579) Nat Genet. 2021 Jun;53(6):801-808. (PMID: 33888907) Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651) Cell. 2015 Mar 12;160(6):1246-60. (PMID: 25748654) J Exp Med. 2019 Dec 2;216(12):2748-2762. (PMID: 31558615) PLoS Genet. 2014 May 15;10(5):e1004383. (PMID: 24830394) Nature. 2017 Aug 31;548(7669):537-542. (PMID: 28783722) Science. 2020 Sep 11;369(6509):1318-1330. (PMID: 32913098) N Engl J Med. 2020 Jun 11;382(24):2372-2374. (PMID: 32302078) |
معلومات مُعتمدة: | R01 MH106842 United States MH NIMH NIH HHS; R01 CA218668 United States CA NCI NIH HHS; R01 AI123155 United States AI NIAID NIH HHS; UM1 HG008901 United States HG NHGRI NIH HHS; DP2 HG010099 United States HG NHGRI NIH HHS; R01 HL142028 United States HL NHLBI NIH HHS |
فهرسة مساهمة: | Keywords: COVID-19; CRISPR; GWAS; SARS-CoV-2; eQTL |
تواريخ الأحداث: | Date Created: 20210421 Latest Revision: 20240403 |
رمز التحديث: | 20240403 |
مُعرف محوري في PubMed: | PMC8057256 |
DOI: | 10.1101/2021.04.09.21255184 |
PMID: | 33880488 |
قاعدة البيانات: | MEDLINE |
DOI: | 10.1101/2021.04.09.21255184 |
---|